


FRAXA Research Foundation Revenue
Non-profit Organizations • Newburyport, Massachusetts, United States • 11-20 Employees
FRAXA Research Foundation revenue & valuation
| Annual revenue | $3,000,000 |
| Revenue per employee | $250,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Non-profit Organizations industry and current estimated revenues | $9,600,000 |
| Total funding | No funding |
Key Contacts at FRAXA Research Foundation
Katie Clapp
President And Executive Director
Holly Usrey-Roos
Community Services Director
Company overview
| Headquarters | 10 Prince Place, Suite 203, Newburyport, MA 01950, US |
| Phone number | +19784621866 |
| Website | |
| NAICS | 813 |
| SIC | 673 |
| Keywords | Autism, Fragile X, Fragile X Syndrome, Fragile X Research |
| Founded | 1994 |
| Employees | 11-20 |
| Socials |
FRAXA Research Foundation Email Formats
FRAXA Research Foundation uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@fraxa.org), used 50% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@fraxa.org | 50% |
{first initial} | j@fraxa.org | 50% |
About FRAXA Research Foundation
FRAXA Research Foundation is a national 501c3 nonprofit organization. FRAXA’s mission is to find effective treatments and ultimately a cure for Fragile X syndrome. We directly fund research grants and fellowships at top universities around the world. We partner with biomedical and pharmaceutical companies, large and small, to bridge the gap between research discoveries and actual treatments. Treatments for Fragile X are likely to help people affected by autism, Alzheimer’s, and other brain disorders. FRAXA also supports families affected by Fragile X syndrome and raises awareness of this important but relatively unknown disease. Fragile X syndrome (FXS) is the most common inherited cause of autism and intellectual disabilities. It affects 1 in 4,000 boys and 1 in 8,000 girls worldwide. Fragile X syndrome occurs when a single gene on the X chromosome shuts down. This gene makes a protein needed for normal brain development. In FXS it does not work properly, the protein is not made, and the brain does not develop as it should. FRAXA was founded in 1994 by three parents of children with Fragile X, Katie Clapp, Michael Tranfaglia MD, and Kathy May, to support scientific research aimed at finding a treatment and a cure for Fragile X. Fragile X research is drastically underfunded, considering its high prevalence, prospects for a cure, and the promise that this research holds for advancing understanding of other disorders like autism, Alzheimer's disease, and X-linked mental retardation.
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Funding Data
FRAXA Research Foundation has never raised funding before.
FRAXA Research Foundation Tech Stack
Discover the technologies and tools that power FRAXA Research Foundation's digital infrastructure, from frameworks to analytics platforms.
Web servers
Programming languages
Frequently asked questions
4.8
40,000 users



